Case number 1:20-cv-00061
Merck Sharp & Dohme B.V. et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 28, 2022 | 77 | Other Document (3) Docket Text:Joint Status Report ( Other Document ) filed by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Jul 21, 2022 | 76 | Order (1) Docket Text:ORDER. ORDERED that the parties herein file a status report apprising this Court of the status of all ongoing litigation related to this matter on or before August 5, 2022. Signed by District Judge John Preston Bailey on 7/21/2022. (dk) |
| Jan 11, 2022 | 74 | Main Document (3) Docket Text: MOTION to Withdraw as Counsel (Christopher Marth) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Jan 11, 2022 | 74 | Proposed Order (1) |
| Jan 11, 2022 | 75 | Order on Motion to Withdraw (1) Docket Text:ORDER GRANTING [74] MOTION TO WITHDRAW. Attorney Christopher Marth terminated. Signed by District Judge John Preston Bailey on 1/11/2022. (dk) |
| Nov 30, 2021 | 73 | Status Report (4) Docket Text: STATUS REPORT Joint Status Report of the Parties by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
| Nov 4, 2021 | 71 | Order Reassigning Case (1) Docket Text:ORDER OF REFERRAL. Case reassigned to District Judge John Preston Bailey for all further proceedings. District Judge Thomas S. Kleeh no longer assigned to case. Signed by District Judge Thomas S. Kleeh on 11/4/2021. (dk) |
| Nov 4, 2021 | 72 | Order (1) Docket Text:ORDER. It is hereby ORDERED that the parties herein file a status report apprising this Court of the status of all ongoing litigation related to this matter on or before November 30. 2021. Signed by District Judge John Preston Bailey on 11/4/2021. (dk) |
| Sep 16, 2021 | 70 | Order Reassigning Case (1) Docket Text:ORDER TRANSFERRING CASE. Case reassigned to District Judge Thomas S. Kleeh for all further proceedings. Senior Judge Irene M. Keeley no longer assigned to case. Signed by Senior Judge Irene M. Keeley on 9/16/021. (dk) |
| Aug 3, 2021 | 69 | Order on Motion to Substitute Party (2) Docket Text:ORDER GRANTING MOTION [68] FOR SUBSTITUTION OF PARTY. Merck Sharp & Dohme Corp. added. Organon USA Inc. terminated. Signed by Senior Judge Irene M. Keeley on 8/3/2021. (dk) |
| Aug 2, 2021 | 68 | Main Document (4) Docket Text: First MOTION to Substitute Party by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Proposed Order)(Brown, Shanna) |
| Aug 2, 2021 | 68 | Proposed Order (2) |
| Jul 11, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM/ECF system to the Next Generation of CM/ECF (NextGen CM/ECF) on July 19, 2021. Preparing for NextGen CM/ECF is a two-step process. Step One was to upgrade your PACER account. Each attorney should have their own individual upgraded PACER account at this time. Step two will be to link your upgraded PACER account to your WVND e-filing account in the new NextGen CM/ECF system on or after July 19, 2021. Instructions for linking your account can be found here.PLEASE NOTE: The WVND CM/ECF system will be unavailable from 1:00 pm on Friday July 16, 2021 until 8:00 am Monday, July 19, 2021. An extension for electronic filing will be granted for all documents with court-imposed deadlines falling between 1:00 pm on Friday, July 16, 2021, and midnight on Sunday, July 18, 2021. All documents due during that period must be filed prior to 1:00 pm Friday, July 16, 2021, or on Monday, July 19, 2021. If you have any additional questions, please contact the PACER Service Center at 800-676-6856 or the WVND Clerks Office CM/ECF Help Desk at (304) 267-5682. (cmd) (ADI) |
| Jun 19, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM?ECF system to Next Generation of CM/ECF (NextGen CM/ECF) on Monday, July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here. Preparing for NextGen Cm/ECF is a two-step process. Step one was to upgrade your PACER account. Each attorney should have their own individual upgraded PACER account at this time. Step two will be to link your upgraded PACER account to your WVND e-fling account in the new NextGen CM/ECF system on or after July 19, 2021. Please log in to the WVND CM/ECF system at https://ecf.wvnd.uscourts.gov/ before July 19, 2021 to make sure you know your current WVND e-filing login and password. Do not rely on your username and password being saved in your web browser, because that method will not work with the NextGen upgrade. If you do not know your login or password or have any additional questions please call the WVND Clerks CM/ECF Office Help Desk at (304) 267-5682. (cmd) (ADI) |
| May 30, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM/ECF system to the Next Generation of CM/ECF (NextGen CM/ECF) on July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here. Currently, many attorneys within a firm may share a single PACER account. This will no longer be allowed with the New WVND NextGen CM/ECF system because each attorney must have an individual upgraded PACER account that will be linked to their e-filing account. Shared PACER accounts cannot be used by WVND e-filing attorneys once the WVND NextGen CM/ECF system is implemented. Preparing for NextGen CM/ECF is a two-step process. Step one is to upgrade your PACER account, and step two is to link your upgraded PACER account to the WVND e-filing account in the upgraded NextGen CM/ECF system. This notice only addresses the first step because the second step cant be completed until on or after July 19, 2021. The first step is to check and see if your PACER account is an upgraded PACER account. Many PACER accounts have already been upgraded. If any of the following is true, you have un upgraded PACER account and no action is required until after the WVND NextGen CM/ECF upgrade occurs on July 19, 2021: 1) You have a an upgraded PACER account for another NextGen court; or 2) Your PACER account was created after August 10, 2014. If none of these are true, you must upgrade your legacy PACER account before you will be able to link your PACER account to your current WVND CM/ECF account for your new NextGen CM/ECF account. Additional notices will be sent later detailing how to handle the second step in this process. If you still have questions, please contact the PACER Service Center at 800-676-6856 or the WVND Clerks Office CM/ECF Help Desk at (304) 267-5682. (cmd) (ADI) |
| Jan 6, 2021 | 67 | Order (1) Docket Text:ORDER CANCELLING STATUS CONFERENCE. The Court CANCELS the status conference in the above-captioned matter currently set for January 21, 2021. The parties should apprise the Court of any developments regarding the defendants' challenge to venue in the first-filed case. Signed by Senior Judge Irene M. Keeley on 1/6/2021. (wrr) |
| Sep 1, 2020 | 66 | Order on Motion to Stay (2) Docket Text: ORDER GRANTING PLAINTIFFS' MOTION TO STAY [DKT. NO. [17]] AND STAYING CASE. The Court SCHEDULED a status conference by telephone on Thursday, January 21, 2021 at 1:00 p.m. Signed by Senior Judge Irene M. Keeley on 9/1/2020. (wrr) |
| Aug 31, 2020 | 62 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [51] Motion for Leave to Appear Pro Hac Vice for Attorney Lisa marie LoGiudice. Signed by Senior Judge Irene M. Keeley on 8/31/2020. (copy counsel of record)(jmm) |
| Aug 31, 2020 | 64 | Order (1) Docket Text: ORDER SCHEDULING TRIAL. The Court held a telephone schedulingconference in this matter and scheduled this case for trial asfollows: Trial date November 14, 2022, 8:30 a.m. (5 days). ALTERNATIVE TRIAL DATE: June 20, 2022, 8:30 a.m. (5 days). Signed by Senior Judge Irene M. Keeley on 8/31/2020. (wrr) |
| Aug 27, 2020 | 61 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [59] Motion for Leave to Appear Pro Hac Vice. Attorney Adam Michael Nicolais for Merck Sharp & Dohme B.V., Organon USA Inc. added. Signed by Senior Judge Irene M. Keeley on 8/27/2020. (wrr) |
| Aug 26, 2020 | 59 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Adam Nicolais by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order)(Fenwick, Carrie) |
| Aug 26, 2020 | 59 | Exhibit A (3) |
| Aug 26, 2020 | 59 | Proposed Order (1) |
| Aug 25, 2020 | 57 | Sealed Motion (1) Docket Text: ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL [DKT. NO. [56]]. Signed by Senior Judge Irene M. Keeley on 8/25/2020. (wrr) |
| Aug 21, 2020 | 50 | Order on Motion for Miscellaneous Relief (1) Docket Text: ORDER granting [48] Motion to Appear. Attorney Andrea Weiss Jeffries for Merck Sharp & Dohme B.V., Organon USA Inc. Signed by Senior Judge Irene M. Keeley on 8/21/2020. (wrr) |
| Aug 21, 2020 | 51 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice for Lisamarie LoGiudice by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order)(Fenwick, Carrie) |
| Aug 21, 2020 | 51 | Exhibit A (3) |
| Aug 21, 2020 | 51 | Proposed Order (1) |
| Aug 21, 2020 | 53 | Main Document (5) Docket Text:Declaration of Sarah A. Geers in Support of Mercks Reply Memorandum in Support of Motion to Stay Other Document filed by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H (Sealed))(Brown, Shanna) |
| Aug 21, 2020 | 53 | Exhibit A (12) |
| Aug 21, 2020 | 53 | Exhibit B (18) |
| Aug 21, 2020 | 53 | Exhibit C (20) |
| Aug 21, 2020 | 53 | Exhibit D (11) |
| Aug 21, 2020 | 53 | Exhibit E (15) |
| Aug 21, 2020 | 53 | Exhibit F (12) |
| Aug 21, 2020 | 53 | Exhibit G (15) |
| Aug 21, 2020 | 53 | Exhibit H (Sealed) (1) |
| Aug 21, 2020 | 54 | Order on Motion to Seal (1) Docket Text: ORDER GRANTING PLAINTIFFS' SECOND MOTION TO SEAL [DKT. NO. [52]]. The Court GRANTS the motion and DIRECTS the Clerk to file Plaintiffs' Reply in Support of its Motion to Stay and its attached declaration under seal. Signed by Senior Judge Irene M. Keeley on 8/21/2020. (wrr) |
| Aug 19, 2020 | 48 | Main Document (2) Docket Text: MOTION Application for Admission Pro Hac Vice for Andrea Weiss Jeffries filed by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order)(Fenwick, Carrie) Modified on 8/19/2020 to correct event (cmd). |
| Aug 19, 2020 | 48 | Exhibit A (3) |
| Aug 19, 2020 | 48 | Proposed Order (1) |
| Aug 14, 2020 | 46 | Order (1) Docket Text: ORDER GRANTING MOTION TO SEAL DKT. NO. [19] Signed by Senior Judge Irene M. Keeley on 8/14/2020. (copy counsel of record)(jmm) |
| Aug 13, 2020 | 38 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Christopher Marth) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Aug 13, 2020 | 38 | Proposed Order (1) |
| Aug 13, 2020 | 39 | Main Document (3) Docket Text: Joint MOTION for Extension of Time to File Response/Reply by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Aug 13, 2020 | 39 | Proposed Order (1) |
| Aug 13, 2020 | 40 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [31] Motion for Brandon M. White to Appear Pro Hac Vice on behalf of Mylan defendants. Signed by Senior Judge Irene M. Keeley on 8/13/2020. (dk) |
| Aug 13, 2020 | 41 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [33] Motion for Shannon M. Bloodworth to Appear Pro Hac Vice on behalf of Mylan defendants. Signed by Senior Judge Irene M. Keeley on 8/13/2020. (dk) |
| Aug 13, 2020 | 42 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [30] Motion for Bryan D. Beel to Appear Pro Hac Vice on behalf of Mylan defendants. Signed by Senior Judge Irene M. Keeley on 8/13/2020. (dk) |
| Aug 13, 2020 | 44 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [38] Motion for Christopher Marth to Appear Pro Hac Vice on behalf of Mylan defendants. Signed by Senior Judge Irene M. Keeley on 8/13/2020. (wrr) |
| Aug 13, 2020 | 45 | Order on Motion for Extension of Time to File Response/Reply (1) Docket Text: ORDER GRANTING [39] JOINT MOTION TO MODIFY REPLY DEADLINES. The Court ORDERS that Merck's Reply in support of Merck's Motion to Stay (ECF No. [17]) andMylan's Reply in support of Mylan's Motion to Dismiss (ECF No. 19-1) shall be filed on or before August 21, 2020. Signed by Senior Judge Irene M. Keeley on 8/13/2020. (wrr) |
| Aug 11, 2020 | 36 | Order on Motion to Seal (1) Docket Text: ORDER GRANTING PLAINTIFFS' MOTION FOR LEAVE TO FILED UNDER SEAL [DKT. NO. [29]]. The Court GRANTS the motion and DIRECTS the Clerk to file Plaintiffs' Brief in Opposition to Mylans Motion to Dismiss and Exhibits 13, 16, 22,23, 24, 25, 26, 28, and 30 to the Declaration of Adam M. Nicolais, Esq. under seal. Signed by Senior Judge Irene M. Keeley on 8/11/2020. (wrr) |
| Aug 7, 2020 | 30 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Bryan D. Beel) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Aug 7, 2020 | 30 | Proposed Order (1) |
| Aug 7, 2020 | 31 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Brandon M. White) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Aug 7, 2020 | 31 | Proposed Order (1) |
| Aug 7, 2020 | 32 | Main Document (6) Docket Text:Declaration of Adam M. Nicolais Esq. in Support of Mercks Opposition to Mylans Motion to Dismiss Other Document filed by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13 (Sealed), # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16 (Sealed), # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22 (Sealed), # (23) Exhibit 23 (Sealed), # (24) Exhibit 24 (Sealed), # (25) Exhibit 25 (Sealed), # (26) Exhibit 26 (Sealed), # (27) Exhibit 27, # (28) Exhibit 28 (Sealed), # (29) Exhibit 29, # (30) Exhibit 30 (Sealed), # (31) Exhibit 31, # (32) Exhibit 32)(Brown, Shanna) (Additional attachment(s) added on 8/11/2020: # (33) Exhibit 13, # (34) Exhibit 16, # (35) Exhibit 22, # (36) Exhibit 23, # (37) Exhibit 24, # (38) Envelope 25, # (39) Envelope 26, # (40) Exhibit 28, # (41) Exhibit 30) (wrr). Modified on 8/11/2020 to file Exhibits 23, 24, 25, 26, 28 and 30 under seal per [36] Order (wrr). |
| Aug 7, 2020 | 32 | Exhibit 1 (5) |
| Aug 7, 2020 | 32 | Exhibit 2 (11) |
| Aug 7, 2020 | 32 | Exhibit 3 (5) |
| Aug 7, 2020 | 32 | Exhibit 4 (4) |
| Aug 7, 2020 | 32 | Exhibit 5 (3) |
| Aug 7, 2020 | 32 | Exhibit 6 (3) |
| Aug 7, 2020 | 32 | Exhibit 7 (4) |
| Aug 7, 2020 | 32 | Exhibit 8 (4) |
| Aug 7, 2020 | 32 | Exhibit 9 (3) |
| Aug 7, 2020 | 32 | Exhibit 10 (78) |
| Aug 7, 2020 | 32 | Exhibit 11 (3) |
| Aug 7, 2020 | 32 | Exhibit 12 (2) |
| Aug 7, 2020 | 32 | Exhibit 13 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 14 (17) |
| Aug 7, 2020 | 32 | Exhibit 15 (10) |
| Aug 7, 2020 | 32 | Exhibit 16 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 17 (2) |
| Aug 7, 2020 | 32 | Exhibit 18 (7) |
| Aug 7, 2020 | 32 | Exhibit 19 (8) |
| Aug 7, 2020 | 32 | Exhibit 20 (17) |
| Aug 7, 2020 | 32 | Exhibit 21 (3) |
| Aug 7, 2020 | 32 | Exhibit 22 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 23 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 24 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 25 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 26 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 27 (19) |
| Aug 7, 2020 | 32 | Exhibit 28 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 29 (202) |
| Aug 7, 2020 | 32 | Exhibit 30 (Sealed) (1) |
| Aug 7, 2020 | 32 | Exhibit 31 (16) |
| Aug 7, 2020 | 32 | Exhibit 32 (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 32 | *Restricted* (7) |
| Aug 7, 2020 | 33 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice (Shannon M. Bloodworth) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(O'Brien, William) |
| Aug 7, 2020 | 33 | Proposed Order (1) |
| Aug 7, 2020 | 34 | Response in Opposition to Motion (15) Docket Text: RESPONSE in Opposition re [17] MOTION to Stay filed by Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| Jul 30, 2020 | 28 | Report of Rule 26(f) Planning Meeting (11) Docket Text: REPORT of Rule 26(f) Planning Meeting. (O'Brien, William) |
| Jul 23, 2020 | 27 | Answer to Counterclaim (7) Docket Text: ANSWER to [20] Answer to Complaint, Counterclaim filed by Mylan Pharmaceuticals Inc. by Merck Sharp & Dohme B.V., Organon USA Inc..(Fenwick, Carrie) |
| Jul 20, 2020 | 25 | Proposed Order -- NOT PRETRIAL (1) Docket Text: Proposed Order inadvertently omitted from re[24] Joint MOTION for Extension of Time to File Parties' Planning Report under Rule 26(f) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Copland, Gordon) |
| Jul 20, 2020 | 26 | Order on Motion for Extension of Time to File (1) Docket Text: ORDER GRANTING JOINT MOTION FOR EXTENSION OF TIME (DKT. NO. [24]). The Court DIRECTS the parties to submit their joint planning report on or before Thursday, July 30, 2020. Signed by Senior Judge Irene M. Keeley on 7/20/2020. (dk) |
| Jul 17, 2020 | 24 | Main Document (3) Docket Text: Joint MOTION for Extension of Time to File Parties' Planning Report under Rule 26(f) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Copland, Gordon) |
| Jul 17, 2020 | 24 | Proposed Order (3) |
| Jul 15, 2020 | 23 | Order on Motion for Extension of Time to File Response/Reply (2) Docket Text: ORDER GRANTING JOINT MOTION FOR EXTENSION OF TIME DKT. NO. [22] AND RESETTING SCHEDULING CONFERENCE. Defendants Response due by 8/7/2020 re [17]Motion to Stay. Plaintiffs Responses due by 8/7/2020 re [19] Motion To Dismiss and Motion To Seal. Scheduling Conference currently set for August 3, 2020 is VACATED. Scheduling Conference by (telephone)set for 8/31/2020 11:00 AM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. Signed by Senior Judge Irene M. Keeley on 7/15/2020 (copy counsel of record) (jmm) |
| Jul 14, 2020 | 22 | Main Document (4) Docket Text: Joint MOTION for Extension of Time to File Response/Reply Deadlines by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Proposed Order)(Fenwick, Carrie) |
| Jul 14, 2020 | 22 | Proposed Order (3) |
| Jul 6, 2020 | 21 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc. identifying Corporate Parent Mylan, N.V. for Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc... (Copland, Gordon) |
| Jul 2, 2020 | 20 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint , COUNTERCLAIM against Merck Sharp & Dohme B.V., Organon USA Inc. by Mylan Pharmaceuticals Inc..(O'Brien, William) |
| Jul 1, 2020 | 17 | Motion to Stay (3) Docket Text: MOTION to Stay by Merck Sharp & Dohme B.V.. (Fenwick, Carrie) |
| Jul 1, 2020 | 18 | Main Document (12) Docket Text: MEMORANDUM in Support by Merck Sharp & Dohme B.V., Organon USA Inc. re [17] MOTION to Stay . (Attachments: # (1) Exhibit A)(Fenwick, Carrie) |
| Jul 1, 2020 | 18 | Exhibit A (2) |
| Jun 20, 2020 | 16 | Stipulation (3) Docket Text: STIPULATION REGARDING RESPONSIVE PLEADING DEADLINE (JULY 2, 2020) by Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc.. (O'Brien, William) |
| May 21, 2020 | 15 | FirstOrder (3) Docket Text: VACATED SCHEDULING CONFERENCE PER DE [23] ORDER 7/15/2020FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 7/6/2020. Rule 26 Meeting Report due by 7/20/2020. Scheduling Conference set for 8/3/2020 01:30 PM in Judge Keeley Chambers before Senior Judge Irene M. Keeley. The scheduling conference SHALL BE by telephone unless otherwise determined. Discovery due by 8/10/2020. Signed by Senior Judge Irene M. Keeley on 5/21/2020. (wrr) Modified on 7/15/2020 (jmm). |
| May 19, 2020 | 12 | Order of Recusal (1) Docket Text: ORDER OF RECUSAL. District Judge Thomas S. Kleeh recused. Case reassigned to Senior Judge Irene M. Keeley for all further proceedings. Signed by District Judge Thomas S. Kleeh on 5/19/2020. (wrr) |
| May 19, 2020 | 13 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [9] Motion for Leave to Appear Pro Hac Vice as to Doug Winnard. Signed by Senior Judge Irene M. Keeley on 5/19/2020. (wrr) Modified on 5/19/2020 to correct docket text (wrr). NEF regenerated. |
| May 19, 2020 | 14 | Order on Motion for Miscellaneous Relief (1) Docket Text: ORDER granting [8] Motion for Leave to Appear Pro Hac Vice as to Sarah A. Geers. Signed by Senior Judge Irene M. Keeley on 5/19/2020. (wrr) |
| May 18, 2020 | 11 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by William J O'Brien on behalf of Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc. (O'Brien, William) |
| May 6, 2020 | 9 | Main Document (2) Docket Text: Amended MOTION for Leave to Appear Pro hac vice Doug Winnard by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order)(Fenwick, Carrie) |
| May 6, 2020 | 9 | Exhibit A (1) |
| May 6, 2020 | 9 | Proposed Order (1) |
| May 5, 2020 | 7 | Main Document (2) Docket Text: Motion/Application for Admission Pro Hac Vice for Doug Winnard filed by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order)(Fenwick, Carrie) Modified on 5/5/2020 to make a motion (wrr). |
| May 5, 2020 | 7 | Exhibit A (1) |
| May 5, 2020 | 7 | Proposed Order (1) |
| May 5, 2020 | 8 | Main Document (2) Docket Text: Motion/Application for Admission Pro Hac Vice for Sarah Geers filed by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order)(Fenwick, Carrie) Modified on 5/5/2020 to make a motion. (wrr). |
| May 5, 2020 | 8 | Exhibit A (3) |
| May 5, 2020 | 8 | Proposed Order (1) |
| Apr 29, 2020 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Organon USA Inc., Merck Sharp & Dohme B.V.. All Defendants. (Fenwick, Carrie) |
| Apr 6, 2020 | 5 | Main Document (15) Docket Text: Other Document re [1] Complaint Exhibits A, B and C filed by Merck Sharp & Dohme B.V., Organon USA Inc.. (Attachments: # (1) Exhibit B, # (2) Exhibit C)(Fenwick, Carrie) |
| Apr 6, 2020 | 5 | Exhibit B (4) |
| Apr 6, 2020 | 5 | Exhibit C (20) |
| Apr 3, 2020 | 4 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint. (mh) |
| Apr 2, 2020 | 1 | Main Document (23) Docket Text: COMPLAINT against Mylan API US LLC, Mylan Inc., Mylan Pharmaceuticals Inc., filed by Organon USA Inc., Merck Sharp & Dohme B.V.Filing Fee $400 Receipt No. 0424-3019337 (Attachments: # (1) Civil Cover Sheet)(mh) |
| Apr 2, 2020 | 1 | Civil Cover Sheet (2) |
| Apr 2, 2020 | N/A | Notice (Other) (0) Docket Text: PAPERLESS NOTICE : Case filing began in CM/ECF shell case, with filing fee being paid through pay.gov (Receipt #0424-3019337) on April 1, 2020. However, filer failed to complete filing process following receipt of payment. Clerk's Office notified filer of incomplete filing and the Complaint was received on April 2, 2020 in the shell case. (mh) |
| Apr 2, 2020 | 3 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement by Merck Sharp & Dohme B.V., Organon USA Inc. identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme B.V., Organon USA Inc... (Fenwick, Carrie) (Main Document 3 replaced on 4/2/2020 with flattened document) (wrr). |
